Global health in foreign policy - And foreign policy in health? Evidence from the BRICS

Health Policy and Planning

Volumn 29, Issue 6, 2014, Pages 763-773

  Watt, Nicola F ^a   Gomez, Eduardo J ^b   McKee, Martin ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Access to medicines; Antiretroviral; BRICS; Emerging economies; Global health diplomacy; TRIPS

Indexed keywords

ANTIRETROVIRUS AGENT;

BRAZIL; CHINA; HEALTH; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HUMAN; INDIA; POLITICS; PROCEDURES; RUSSIAN FEDERATION; SOCIAL JUSTICE; SOUTH AFRICA;

ANTI-RETROVIRAL AGENTS; BRAZIL; CHINA; DELIVERY OF HEALTH CARE; GLOBAL HEALTH; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HUMANS; INDIA; POLITICS; RUSSIA; SOCIAL JUSTICE; SOUTH AFRICA;

EID: 84901710859     PISSN: 02681080     EISSN: 14602237     Source Type: Journal    
DOI: 10.1093/heapol/czt063     Document Type: Article

References (105)

1. Abbott R. 2007. Are developing countries deterred from using the WTO dispute settlement system? Brussels, European Centre for International Political Economy.
2. Aginam O. 2010. Health or trade? A critique of contemporary approaches to global health diplomacy. Asian Journal of WTO & International Health Law and Policy 5: 355-80.
3. Alavi A. 2007. African countries and the WTO's dispute settlement mechanism. Development Policy Review 25: 25-42.
4. Aldis W. 2008. Health security as a public health concept: a critical analysis. Health Policy and Planning 23: 369-75.
5. Almeida C, Pires de Campos R, Buss P, Ferreira JR, Fonseca LE. 2010. Brazil's conception of South-South 'structural cooperation' in health. Revista Eletrônica de Communicação Informação & Inovaçã o e m Saúde 4: 23-32.
6. Amorim C, Douste-Blazy P, Wirayuda H et al. 2007. Oslo Ministerial Declaration - global health: a pressing foreign policy issue of our time. Lancet 369: 1373-8.
7. Armijo LE. 2007. The BRICs countries (Brazil, Russia, India, and China) as analytical category: mirage or insight? Asian Perspective 31: 7-42.
8. Bhattacharya S. 2004. Uncertain advances - a review of the final phases of the smallpox eradication program in India, 1960-1980. American Journal of Public Health 94: 1875-83.
9. Bischoff PH. 2009. Reform in defence of sovereignty: South Africa in the UN Security Council, 2007-2008. Africa Spectrum 44: 95-110.
10. Bliss KE. 2010. Health in All Policies: Brazil's Approach to Global Health within Foreign Policy and Development Cooperation Initiatives: Key Players in Global Health: How Brazil, Russia, India, China and South Africa are Influencing the Game. Washington DC: CSIS Global Health Policy Center.
11. BRICS Health Ministers. 2011. BRICS Health Ministers' Meeting: Beijing Declaration. http://keionline.org/node/1183, accessed 2 April 2013.
12. BRICS Information Centre. 2013. BRICS and Africa: Partnership for Development, Integration and Industrialisation. The Thekwini Declaration. Durban, South Africa, March 27, 2013. http://www.brics.utoronto.ca/docs/130327-statement.html, accessed 28 March 2013.
13. Burges SW. 2006. Without sticks or carrots: Brazilian Leadership in South America during the Cardoso Era, 1992-2003. Bulletin of Latin American Research 25: 23-42.
14. Burki TK. 2012. Indian government awards compulsory licence for sorafenib. Lancet Oncology 13: e146.
15. Buss PM, Ferreira J, Horisch C. 2011. A saúde pública no Brasil e a cooperaçã interancional. Revista Brasileira de Ciência, Technologia e Sociedade 2: 213-29.
16. Buss PM, Ferreira JR 2010. Critical essay on international cooperation in health. Revista Eletrônica de Communicação Informação & Inovaçã o em Saúde 4: 86-97.
17. Carrara S. 1996. A geopolítica simbólica da sífilis: um ensaio de antropologia histórica. História, Ciências, Saúde - Manguinhos 3: 391-408.
18. Chan LH, Chen L, Xu J. 2010. China's engagement with global health diplomacy: was SARS a watershed? Plos Medicine 7: e1000266.
19. Cooke JG. 2010. South Africa and Global Health: Minding the Home Front First. Washington DC: CSIS Global Health Policy Center.
20. Deloitte. 2010. Insights into the High-level Financial Contribution of the Pharmaceutical Industry in South Africa. Innovative Medicines South Africa. Houghton: Innovative Medicines South Africa.
21. Department of Health. 2003. Operational Plan for Comprehensive HIV and AIDS Care, Management and Treatment for South Africa. Pretoria: Department of Health.
22. Department of Trade and Industry. 2010. 2010/11-2012/13 Industrial Policy Action Plan. Pretoria: DTI.
23. Dukkipati U. 2010. India's Approach to Global Health: Innovation at Home. Washington DC: CSIS Global Health Policy Center.
24. Embassy of India in Madrid. 2012. Overview of Pharmaceutical Sector in India-Opportunities: A guide to do business in India. http://www.india-opportunities.es/pharmaceuticalindustry.php?lang=ing&sub=overview, accessed 1 August 2013.
25. Feldbaum H, Lee K, Michaud J. 2010. Global health and foreign policy. Epidemiologic Reviews 32: 82-92.
26. Feldbaum H, Michaud J. 2010. Health diplomacy and the enduring relevance of foreign policy interests. Plos Medicine 7: e1000226.
27. Fidler DP. 2010. Asia's participation in global health diplomacy and global health governance. Asian Journal of WTO & International Health Law and Policy 5: 269-300.
28. Fidler DP, Drager N. 2006. Health and foreign policy. Bulletin of the World Health Organization 84: 687.
29. Flynn M. 2013. Brazilian pharmaceutical diplomacy: social democratic principles versus soft power interests. International Journal of Health Services 43: 67-89.
30. Freeman CW, Boynton XL 2010. A Bare (but Powerfully Soft) Footprint: China's Global Health Diplomacy. Washington DC: CSIS Global Health Policy Center.
31. Friedman S, Mottiar S. 2005. A rewarding engagement? The treatment action campaign and the politics of HIV/AIDS. Politics & Society 33: 511-65.
32. Galvao J. 2004. Access to antiretrovirals: where South Africa, China, and Brazil meet. Lancet 363: 493.
33. Galvao J. 2005. Brazil and access to HIV/AIDS drugs: a question of human rights and public health. American Journal of Public Health 95: 1110-6.
34. Gelders S, Ewen M, Noguchi N., Laing R. 2005. Price, Availability and Affordability. An International Comparison of Chronic Disease Medicines. Background Report prepared for the WHO Planning Meeting on the Global Initiative for Treatment of Chronic Diseases. Cairo: Health Action International/WHO.
35. GHSI. 2012. Shifting Paradigm: How the BRICS are Reshaping Global Health and Development. New York: Global Health Strategies initiatives.
36. Gómez EJ. 2011. How Brazil outpaced the United States when it came to AIDS: the politics of civic infiltration, reputation, and strategic internationalization. Journal of Health Politics, Policy and Law 36: 317-52.
37. Gómez EJ. 2012. Understanding Brazilian global health diplomacy: social health movements, institutional infiltration, and the geopolitics of accessing AIDS medication. Global Health Governance 5: 1-29.
38. Greene W. 2007. The Emergence of India's Pharmaceutical Industry and Implications for the U.S. Generic Drug Market. Washington DC: Office of Economics, U.S. International Trade Commission.
39. Grover A, Citro B. 2011. India: access to affordable drugs and the right to health. Lancet 377: 976-7.
40. Guebert J. 2012. Russia's Global Health Leadership. Washington DC: Center for Strategic and International Studies.
41. Herbst J. 2005. Mbeki's South Africa. Foreign Affairs 84: 93-105.
42. Hesketh T, Ye X, Zhu W. 2008. Syphilis in China: the great comeback. Emerging Health Threats Journal 1: e6.
43. Hill PS. 2011. Understanding global health governance as a complex adaptive system. Global Public Health 6: 593-605.
44. HM Government. 2008. Health is Global: A UK Government Strategy 2008-13. London: HM Government.
45. HM Government. 2011. Health is Global: An Outcomes Framework for Global Health 2011-15. www.dh.gov.uk/prod-consum-dh/groups/dh-digitalassets/documents/digitalasset/dh-125671.pdf.
46. Huang Y. 2006. The politics of HIV/AIDS in China. Asian Perspective 30: 95-125.
47. Hurrell A. 2006. Hegemony, liberalism and global order: what space for would-be great powers? International Affairs 82: 1-19.
48. International Centre for Trade and Sustainable Development. 2007. Brazil Grants Compulsory License. May 2007. Bridges 11: 1.
49. Katz R, Singer DA 2007. Health and security in foreign policy. Bulletin of the World Health Organization 85: 233-4.
50. Kaufman J. 2009. The role of NGOs in China's AIDS crisis. In: Schwartz J, Shieh S (eds). State and Society Responses to Social Welfare Needs in China. Oxford: Routledge, pp. 156-74.
51. Kay A, Williams O. 2009. The international economy of global health governance. In: Kay A, Williams O (eds). Global Health Governance: Crisis, Institutions and Political Economy. London: Palgrave, pp. 1-24.
52. Kickbusch I. 2011. Global health diplomacy: how foreign policy can influence health. British Medical Journal 342: d3154.
53. Kickbusch I, Berger C. 2011. Global health diplomacy. In: Parker R, Sommer M (eds). Routledge Handbook of Global Public Health. London: Routledge, pp. 275-81.
54. Kickbusch I, Erk C. 2009. Global Health Diplomacy: the new recognition of health in foreign policy. In: Clapham A, Robinson M (eds). Realizing the Right to Health, pp. 517-24.
55. Kickbusch I, Lister G, Told M., Drager N. 2013. Global Health Diplomacy: Concepts, Issues, Actors, Instruments, Fora and Cases. New York: Springer.
56. Kickbusch I, Silberschmidt G, Buss P. 2007. Global health diplomacy: the need for new perspectives, strategic approaches and skills in global health. Bulletin of the World Health Organization 85: 230-2.
57. Kirton JJ, Mannell J. 2007. The G8 and Global health governance. In: Cooper AF, Kirton JJ, Schrecker T (eds). Governing Global Health: Challenge, Response, Innovation. Aldershot: Ashgate, pp. 115-46.
58. Kulik J. Russia's Global Health Governance Gap: A Strategy for Summit Success. Paper presented at Conference on Emerging Practices in Global Health Cooperation, Washington, DC, 13 December 2011. Unpublished Document.
59. Kumar AK, Chen LC, Choudhury M et al. 2011. Financing health care for all: challenges and opportunities. Lancet 377: 668-79.
60. Labonte R, Gagnon ML 2010. Framing health and foreign policy: lessons for global health diplomacy. Globalization and Health 6: 14.
61. Lee K. 2009. Understandings of global health governance: the contested landscape. In: Kay A, Williams O (eds). Global Health Governance: Crisis, Institutions and Political Economy. London: Palgrave, pp. 27-41.
62. Lee K, Sridhar D, Patel M. 2009. Trade and Health 2 Bridging the divide: global governance of trade and health. Lancet 373: 416-22.
63. Lipton M. 2009. Understanding South Africa's foreign policy: the perplexing case of Zimbabwe. South African Journal of International Affairs 16: 331-46.
64. Looney W. 2010. Strategies for emerging markets: seven keys to the Kingdom. Pharmaceutical Executive 30: http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=682854.
65. Macfarlane SN. 2006. The 'R' in BRICs: is Russia an emerging power? International Affairs 82: 41-57.
66. Malysheva T. 2011. Pharma 2020: The Strategy of Development of the Pharmaceutical Industry of the Russian Federation Embassy of Switzerland in the Russian Federation. Moscow: Embassy of Switzerland in the Russian Federation.
67. McInnes C, Lee K. 2006. Health, security and foreign policy. Review of International Studies 32: 5-23.
68. McIntyre D, Thiede M, Nkosi M et al. 2007. A Critical Analysis of the Current South African health system. Cape Town: University of Cape Town and University of the Witwatersrand.
69. McKee M. 2007. A UK global health strategy: the next steps. BMJ 335: 110.
70. Ministers of Health of Brazil China India Russian Federation and South Africa. 2010. Press Release of Ministers of Health of Brazil, China, India, Russian Federation and South Africa. Geneva: Permanent Mission of the People's Republic of China to the United Nations.
71. Mogedal S, Alveberg BL 2010. Can foreign policy make a difference to health? Plos Medicine 7: e1000274.
72. Nassmacher H. 2008. The dilemma of depth versus breadth in comparing political systems empirically⋯ and how to overcome it. European Political Science 7: 113-25.
73. Nattrass N. 2007. Mortal Combat: AIDS Denialism and the Struggle for Antiretrovirals in South Africa. Scottsville: University of Kwa Zulu-Natal Press.
74. Nunn A, Da Fonseca E, Gruskin S. 2009. Changing global essential medicines norms to improve access to AIDS treatment: lessons from Brazil. Global Public Health 4: 131-49.
75. Nunn AS, Fonseca EM, Bastos F.I., Gruskin S., Salomon JA. 2007. Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment. Plos Medicine 4: e305.
76. O'Neill J. 2001. Building Better Global Economic BRICs: Global Economics Paper No: 66. London: Goldman Sachs.
77. Panova VV. 2005. Russia in the G8: from Sea Island 2004 to Russia 2006. In: Fratianni M, Kirton JJ, Rugman AM, Savona P (eds). New Perspectives on Global Governance: Why America Needs The G8. Aldershot: Ashgate, pp. 51-66.
78. Panova VV. 2007. Russia and the G8: matured partnership. In: Fratianni M, Kirton JJ, Savona P (eds). Financing Development: The G8 and UN Contribution. Aldershot: Ashgate, pp. 99-120.
79. Rolland SE. 2007. Developing country coalitions at the WTO: in search of legal support. Harvard International Law Journal 48: 483-551.
80. Rushton S. 2011. Global health security: security for whom? Security from what? Political Studies 59: 779-96.
81. Russo G, Shankland A. 2014. Brazil's engagement in health cooperation: what can it contribute to the global health debate? Health Policy and Planning 29: 266-70.
82. Schneider H. 2002. On the fault-line: the politics of AIDS policy in contemporary South Africa. African Studies 61: 145-67.
83. Sebrie EM, Blanco A, Glantz SA 2010. Cigarette labeling policies in Latin America and the Caribbean: progress and obstacles. Salud Publica de Mexico 52(Suppl. 2):S233-43.
84. Shine. 2012. Pharmaceuticals Industry India, Vol. 2012. India: Shine.
85. Sidiropoulos E. 2008. South African foreign policy in the post-Mbeki period. South African Journal of International Affairs 15: 107-20.
86. Sjöstedt R. 2008. Exploring the construction of threats: the securitization of HIV/AIDS in Russia. Security Dialogue 39: 7-29.
87. Skocpol T, Somers M. 1980. The uses of comparative history in macrosocial inquiry. Comparative Studies in Society and History 22: 174-97.
88. Smith RD, Correa C, Oh C. 2009. Trade and Health 5 Trade, TRIPS, and pharmaceuticals. Lancet 373: 684-91.
89. Sridhar D, Gómez EJ. 2011. Health financing in Brazil, Russia and India: what role does the international community play? Health Policy and Planning 26: 12-24.
90. Stuckler D, McKee M. 2008. Five metaphors about global-health policy. Lancet 372: 95-7.
91. Teixeira PR. 2003. Universal access to AIDS medicines: the brazilian experience. Divulgação em Saúde para Debate 27: 184-91.
92. Times of India. 2010. SC Forces Govt to Agree to Second-line ART to all AIDS Patients. http://articles.timesofindia.indiatimes.com/2010-12-11/india/28231314-1-hiv-patients-second-line-treatment-second-line-drugs, accessed 28 March 2013.
93. UNAIDS. 2010. UNAIDS Report on the Global AIDS Epidemic. Geneva: UNAIDS.
94. UN Secretary General. 2009. Note by the Secretary-General A/64/365. Global Health and Foreign Policy: Strategic Opportunities and Challenges. www.who.int/trade/foreignpolicy/en/.
95. Vidyasagar D. 2010. Global notes: the interactions of health and foreign policies. Journal of Perinatology 30: 643-4.
96. Wallander CA. 2005. The Politics of Russian AIDS Policy. Washington DC: Center for Strategic and International Studies.
97. Weyland K. 1995. Social Movements and the State: The Politics of Healthcare Reform in Brazil. World Development 23: 1699-72.
98. World Health Organisation. 1956. Cardiovascular Disease and Hypertension in: WHA9. 31. Geneva: Switzerland.
99. World Health Organisation. 2010. Towards Universal Access Scaling up Priority HIV/AIDS Interventions in the Health Sector 2010 Progress Report. Geneva: World Health Organisation.
100. World Health Organisation. 2012. Implementation of the International Health Regulations (2005): Report by the Director-General. EB 132/15. Geneva: World Health Organisation.
101. Xinhua. 2011. Sanya Declaration of the BRICS Leaders Meeting. China Daily. http://www.chinadaily.com.cn/china/brics2011/2011-04/14/content-12329531.htm.
102. Yach D, Hawkes C, Gould C.L., Hofman KJ. 2004. The global burden of chronic diseases - overcoming impediments to prevention and control. JAMA 291: 2616-22.
103. Youla C. 2009. The Foreign Policies of Mandela and Mbeki: a clear case of idealism vs realism? Department of Political Science, Master of Arts (International Studies). South Africa: Stellenbosch University, pp. 1-84.
104. Yu PK. 2008. Access to medicines, BRICS alliances, and collective action. American Journal of Law & Medicine 34: 345-94.
105. Zunyou W, Sullivan S. 2006. China. In: Yamamoto T, Itoh S (eds). Fighting a Rising Tide: The Response to AIDS in East Asia. Tokyo: Japan Center for International Exchange, pp. 76-95.